PAUL LI: Open Payments
NPI 1053325407 · FLUSHING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,558 in 66 payments from 9 companies in 2025. Trend: 2023 $1,698 · 2024 $2,121 · 2025 $1,558
Food & beverage: $1,558
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 19 | $595 |
| AstraZeneca Pharmaceuticals LP | 8 | $246 |
| Amgen Inc. | 13 | $243 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $162 |
| ABBVIE INC. | 9 | $152 |
| Lilly USA, LLC | 3 | $70 |
| Sumitomo Pharma America, Inc. | 3 | $57 |
| PFIZER INC. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
Products named: Kerendia, BREZTRI, OTEZLA, LINZESS, EVENITY, AIRSUPRA, JARDIANCE, GEMTESA.
Industry payments across NY — which companies pay providers there.
